Goran Stankovic, MD, PhD

Here @GoranEBC shows us how he used imaging in this case, this is like seeing converts to new religions! Those non imaging experts joining the imaging revolution is music to quality! @mmamas1973 @twj1974 Image says @EAPCIPresident #EAPCI26 I have seen Goran 100+ times,teacher!

LIVE Educational Case: Provisional left main stenting after lesion preparartion guided by IVUS Learn from replay📺pcronline.com/Cases-resource… Operators: @DrShereen_ @FBardooli Procedural Analyst: @GoranEBC Key moments 🟣33:05–43:28 : Lesion preparation - IVL 🟣51:20–54:28 : Left main - LAD stenting 🟣24:00–31:20, 43:42–50:40, 58:20–1:01:50, 1:10:27–1:17:20 : IVUS at each step This case has been editorialised by @MartineGilard #GulfPCR #interventionalcardiology #imagefirst #cardioed

We have date for the next EBC meeting in Copenhagen!!!LM intervention after TAVI, DCB for bifurcation lesions, plaque modification in complex bif, complications in bif intervention, consensus about Cx ostium interventions and ICI for LM PCI and more. @GoranEBC @BURZOTTA_F

EPIC 2026 is coming fast—April 16–17. Register now, epic2026.org and get ready for something amazing! 📅 April 16–17, 2026 📍 Atlanta, GA 🔹 In‑Person Only 🔹 Limited to 250 Attendees 🔹 No Registration Fees youtu.be/4gKJ1bsCXYw

@Hragy Thank you very much @Hragy

#EAPCI26 @GoranEBC is very gently explaining the step wise approach for imaging guided PCI

Nikola Jokic is the only player in NBA history to record 1,000 points, 475 rebounds, 400 assists, 250 made free throws, 75 made threes, and 30 blocks before the All-Star break. Just incase your forgot, he also missed 16 games

TUXEDO-2, in plain terms. The trial was designed to test non-inferiority of ticagrelor vs prasugrel in patients with diabetes and multivessel disease, using a composite endpoint mixing ischemic and bleeding events. The NI margin was 5%, but the 95% CI of the difference ranged from −2.07% to +6.74%. To me, this is an inconclusive result: it cannot confidently rule out benefit or harm. Still, I’m comfortable with the authors’ and the journal’s conclusion—ticagrelor did not meet non-inferiority, seemingly due to numerical increases in both ischemic and bleeding events. This is now the second trial suggesting that the two drugs are not exactly on the same level. Ticagrelor was not superior to prasugrel in ISAR-REACT 5, and it was not non-inferior in TUXEDO-2. This may sound like nuance, but it’s actually the key point. In both trials, ticagrelor was the one being tested against prasugrel, not the other way around. The burden of proof was on ticagrelor—and it didn’t quite carry it. With the comparison reversed, and given these statistical designs and endpoints, results might have been the same, or maybe not. Add to this that one trial was in ACS and the other not strictly so, and the picture becomes even more blurred. Bottom line: we really need a patient-level meta-analysis. A study-level one would probably just add another layer of confusion. jamanetwork.com/journals/jamac…

Plaque rupture with thrombosis drives ACS, and thin-cap fibroatheroma is the archetypal high-risk plaque. There are consistent features of vulnerability across imaging modalities (large plaque burden, small MLA, TCFA, high LCBI, positive remodelling, etc.), with risk increasing when multiple features coexist. Yet absolute event rates remain low, consistent with pathology data showing most plaque ruptures are clinically silent. So should we prophylactically stent high-risk plaques? According to this Viewpoint, completed trials (PROSPECT ABSORB, PREVENT) suggest no durable reduction in death or MI versus optimal medical therapy—benefits are limited to fewer revascularisations, at the cost of many unnecessary PCIs. With modern medical therapy, a wait-and-see strategy appears safe, avoiding most interventions without adverse consequences. For now, data favor surveillance and aggressive medical therapy over preventive PCI. READ THE VIEWPOINT: eurointervention.pcronline.com/article/high-r…

Thank you 🙏 to the 45 participants who attended our first PCR Seminar of the year in Tbilisi 🇬🇪 with facilitators @GoranEBC and @FlavioRibichini This seminar focused on the 'Management of patients with bifurcation lesions with or without a left main disease' Thank you so much to our local hosts for their welcome: despite the snow ❄️ outside, the atmosphere inside was warm, engaging, and focused on shared learning! #interventionalcardiology #cardioed

Great meeting in Tbilisi, Georgia.🇬🇪 Organized by #medtronic and #PCR @GoranEBC @FlavioRibichini

PCRonline science & education highlights of 2⃣0⃣2⃣5⃣: most viewed #PCRwebinar 📺 Congratulations to @GoranEBC, @burzotta_f, @M_Lesiak and Fahim H. Jafary whose webinar on how to treat ostial left circumflex stenosis was the most viewed in 2025! #ICYMI, you can still learn from it here pcronline.com/Webinars/PCR-W… @MilasinD18 #CardioEd #interventionalcardiology

Our core lab OCT substudy from ECLIPSE now publ in Circ CV Int. Although 98.1% of 578 lsns were severely calcified by angio, <half met OCT criteria for severe calc (arc ≥270°). Min stent area was not larger w/atherectomy vs balloon pre-dil, even in severe lsns. Happy new year!🎉

Join us for EPIC 2026 and be part of an exceptional experience. Register now at epic2026.org

Join us for EPIC 2026 and be part of an exceptional experience. Register now at epic2026.org

18th European #Bifurcation Club Consensus This expert document outlined a refined framework for optimising angiography-guided PCI in coronary bifurcation lesions—focusing on meticulous pre-PCI imaging review, accurate bifurcation sizing, strict adherence to technical steps (incl. POT, DOT, rewiring strategy), and systematic use of stent-enhancement tools to ensure optimal stent expansion and apposition. #EIJBestOf eurointervention.pcronline.com/article/percut… @BURZOTTA_F @GoranEBC @flensted_jens @ColletCarlos @YChatzizisis

How can coronary bifurcation PCI be simplified? Post-session at #GulfPCR, @FBardooli spoke with @GoranEBC to look back on the tips and tricks he shared with the audience⬇️

LIVE Educational Case of the week: DK crush technique in a left main distal stenosis Replay 📺pcronline.com/Cases-resource… (access via your free My PCR account) A 52-year-old male with prior STEMI presents with severe, calcified LAD, CX, and distal left main disease. Key moments 21:37-24:38 - LAD IVUS run 32:37-34:23 - CX IVUS run 44:14-01:10:50 - DK crush technique step-by-step Operators: M. Grygier, @M_Lesiak Procedural Analyst: J. Legutko Speakers: @GoranEBC , @MartineGilard #interventionalcardiology

Friends

Happy to be speaking at the LEFT MAIN BIFURCATION CONCLAVE by EBC ( European BIFURCATION CLUB) Great discussions and learnings. Excellent inputs from @GoranEBC @DrPeterOKane @soledadojeda @alaide_chief @drsonyaburgess @APSIC6 @WomenAs1 @IJCDW_WINCARS @mmamas1973 @Hragy @mirvatalasnag